research use only
Cat.No.S1067
| Related Targets | PKC ROCK Bcr-Abl |
|---|---|
| Other TGF-beta/Smad Inhibitors | RepSox (E-616452) Vactosertib (TEW-7197) A-83-01 LDN-193189 Dihydrochloride Galunisertib (LY2157299) SRI-011381 (C381) LY2109761 SIS3 Hydrochloride SB-525334 LY364947 |
|
In vitro |
DMSO
: 77 mg/mL
(200.31 mM)
Ethanol : 3 mg/mL Water : Insoluble The solubility data above are all experimental results (not literature values). |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
Read more about SB431542 working concentrations for cell culture treatment
| Information | SB431542 is a potent, highly selective, and ATP-competitive TGF-beta type I receptor kinase (ALK4/5/7) inhibitor. It works by blocking the receptor kinase activity, preventing the phosphorylation of Smad2/3 and disrupting downstream TGF-beta/Smad signaling. This effectively suppresses epithelial-mesenchymal transition, fibrosis, and cancer metastasis, showing significant application value in stem cell differentiation and regenerative medicine. |
|---|---|
| Primary Applications and Mechanism of Action |
| Molecular Weight | 384.39 | Formula | C22H16N4O3 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 301836-41-9 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | C1OC2=C(O1)C=C(C=C2)C3=C(NC(=N3)C4=CC=C(C=C4)C(=O)N)C5=CC=CC=N5 | ||
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.
Question 1:
I would appreciate it if you can help me in figuring out the formulation for it in vivo experiments.
Answer:
S1067 in 1% DMSO+30% polyethylene glycol+1% Tween 80 at 30 mg/ml is a suspension for oral gavage. It can also be dissolved in 2% DMSO+30% PEG 300+ddH2O at 5 mg/ml as a clear solution for IP injection.